187 results
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
as exclusive agent of the Company for the purpose of selling the Shares of the Company pursuant to this Agreement, and the Manager agrees to use its … or the institution or threatening of any proceeding for that purpose and (v) of the receipt by the Company of any notification with respect
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements … exchange” or other market within the meaning of applicable U.S. Treasury regulations. For this purpose, our common shares generally should be considered
8-K
EX-10.1
i9ftkm6lqlbr1
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-4.2
xe5f1glqw
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-4.1
k61747shaa peq6
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
424B5
g7pvzvujvm60eenxe
11 Apr 24
Prospectus supplement for primary offering
9:06am
8-K/A
inz7s3 hj984
27 Jul 23
Submission of Matters to a Vote of Security Holders
4:05pm
424B5
0o3k 83wx1zj8pc
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
57j35av
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-4.1
uvl 15ny77njvw26d8v
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-1.1
kekg25rwpvg0
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm